Florin Floricel

UCB Pharma (Germany) — Germany

Medicine · Health Sciences

6h-index95citations23works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(22), Pharmacological Effects and Toxicity Studies(17), Neuroscience and Neuropharmacology Research(9), Attention Deficit Hyperactivity Disorder(5), Pharmaceutical studies and practices(3)

Publications23 total

Treatment with brivaracetam has no apparent long‐term effects on body weight in pediatric patients with epilepsy
Epilepsia Open·2024· 1 citedOpen Access
Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy
Epilepsy & Behavior·2024· 1 citedOpen Access
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies
Epilepsy & Behavior·2024· 9 citedOpen Access
Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures
Epilepsy & Behavior·2024· 1 citedOpen Access
12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE Pooled Analysis (P8-1.009)
Neurology·2024
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis
Journal of Neurology·2024· 11 citedOpen Access
Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures: A multicenter, open‐label, single‐arm study
Epilepsia Open·2023· 8 citedOpen Access
Efficacy and tolerability of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed temporal lobe epilepsy: Post hoc analysis of a randomized, double-blind trial
Seizure·2023· 3 citedOpen Access
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
CNS Drugs·2023· 21 citedOpen Access
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial
Epilepsia·2023· 17 citedOpen Access
Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open‐label exploratory trial
Epilepsia·2023· 5 citedOpen Access
2576 12-Month effectiveness and tolerability of brivaracetam in patients with epilepsy switching from levetiracetam Vs Other antiseizure medications in the real-world
2023Open Access
2628 12-Month effectiveness and tolerability of brivaracetam in the real-world in the international EXPERIENCE pooled analysis: final results and Australian subgroup
2023Open Access
12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003)
Neurology·2023
Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial (P14-1.007)
Neurology·2023
Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
Epilepsia Open·2022· 5 citedOpen Access
Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study
Drug Safety·2022· 3 cited
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials
Epilepsia·2022· 7 citedOpen Access
Time-course of Treatment-emergent Adverse Events Potentially Associated with Behavioral Disorders during Adjunctive Brivaracetam Treatment of Adults with Focal Seizures (P17-8.003)
Neurology·2022
Cognitive and Behavioral Effects and Tolerability of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Pooled Interim Analysis (P13-8.004)
Neurology·2022
page 1 of 2Next →

Frequent Co-authors

Cédric Laloyaux(10), Tony Daniels(9), Wendyl D’Souza(8), Pavel Klein(8), Javier Salas‐Puig(8), Adam Strzelczyk(8), Jerzy P. Szaflarski(8), Bernhard J. Steinhoff(8), Vicente Villanueva(7), Edward Faught(7), Markus Reuber(7), Felix Rosenow(7), Víctor Soto Insuga(7), Hervé Besson(7), Dimitrios Bourikas(7), David Friesen(6), Veronica Sendersky(6), Jan‐Peer Elshoff(6), Svetlana Dimova(6), Christoph Reichel(4)